Aspen Aerogels Inc (ASPN) concluded trading on Wednesday at a closing price of $11.75, with 3.74 million shares of worth about $43.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.00% during that period and on February 12, 2025 the price saw a loss of about -3.21%. Currently the company’s common shares owned by public are about 82.05M shares, out of which, 80.83M shares are available for trading.
Stock saw a price change of 4.17% in past 5 days and over the past one month there was a price change of -7.70%. Year-to-date (YTD), ASPN shares are showing a performance of -1.09% which decreased to -2.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.67 but also hit the highest price of $33.15 during that period. The average intraday trading volume for Aspen Aerogels Inc shares is 1.78 million.
Aspen Aerogels Inc (NYSE: ASPN) currently have 82.05M outstanding shares and institutions hold larger chunk of about 87.91% of that.
The stock has a current market capitalization of $964.05M and its 3Y-monthly beta is at 2.22. PE ratio of stock for trailing 12 months is 1049.11, while it has posted earnings per share of $0.01 in the same period. Its PEG reads 11.42 and has Quick Ratio of 2.48 while making debt-to-equity ratio of 0.40. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ASPN, volatility over the week remained 6.22% while standing at 5.62% over the month.
Stock’s fiscal year EPS is expected to rise by 145.75% while it is estimated to increase by 87.30% in next year. EPS is likely to grow at an annualized rate of 91.83% for next 5-years, compared to annual growth of 14.58% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barclays on August 06, 2024 offering an Overweight rating for the stock and assigned a target price of $27 to it. Coverage by ROTH MKM stated Aspen Aerogels Inc (ASPN) stock as a Buy in their note to investors on March 06, 2024, suggesting a price target of $22 for the stock. On March 20, 2023, The Benchmark Company Upgrade their recommendations, while on October 21, 2022, Canaccord Genuity Resumed their ratings for the stock with a price target of $20. Stock get a Buy rating from The Benchmark Company on December 10, 2021.
